Merkel Cell Carcinoma: More Deaths but Still No Pathway to Blame
- 1 September 2007
- journal article
- editorial
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 127 (9), 2100-2103
- https://doi.org/10.1038/sj.jid.5700925
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Activation of the MAP Kinase Pathway Induces Apoptosis in the Merkel Cell Carcinoma Cell Line UISOJournal of Investigative Dermatology, 2007
- Hyperactive Ras in developmental disorders and cancerNature Reviews Cancer, 2007
- The Wnt‐signaling pathway is not implicated in tumorigenesis of Merkel cell carcinomaJournal of Cutaneous Pathology, 2006
- Merkel cell carcinoma: evaluation of KIT (CD117) expression and failure to demonstrate activating mutations in the C‐KIT proto‐oncogene – implications for treatment with imatinib mesylateJournal of Cutaneous Pathology, 2006
- Absence of Classical MAP Kinase Pathway Signalling in Merkel Cell CarcinomaJournal of Investigative Dermatology, 2006
- Merkel cell carcinoma: Changing incidence trendsJournal of Surgical Oncology, 2004
- Epidemiology of primary Merkel cell carcinoma in the United StatesJournal of the American Academy of Dermatology, 2003
- UV‐B‐type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomasInternational Journal of Cancer, 2002
- Bcl-2 Antisense Oligonucleotides (G3139) Inhibit Merkel Cell Carcinoma Growth in SCID MiceJournal of Investigative Dermatology, 2000
- Expression of bcl-2 and p53 in Merkel Cell CarcinomaThe American Journal of Dermatopathology, 1996